Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | +7.32% |
|
+22.71% | -48.56% |
Jul. 01 | NovaBay Pharmaceuticals, Eyenovia Begin Co-Promotion Deal Activities | MT |
Jul. 01 | NovaBay Pharmaceuticals, Inc. and Eyenovia, Inc. Commence Co-Promotion Activities | CI |
Financials (USD)
Sales 2024 * | 3.54M | Sales 2025 * | 11.6M | Capitalization | 73.85M |
---|---|---|---|---|---|
Net income 2024 * | -31M | Net income 2025 * | -42M | EV / Sales 2024 * | 20.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.37 x |
P/E ratio 2024 * |
-1.58
x | P/E ratio 2025 * |
-1.2
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.14% |
Latest transcript on Eyenovia, Inc.
1 day | +7.32% | ||
1 week | +22.71% | ||
Current month | +80.10% | ||
1 month | +72.00% | ||
3 months | +101.89% | ||
6 months | -38.15% | ||
Current year | -48.56% |
![Extreme 0.8598](/images/extremecours_fleche.png)
![Extreme 0.5941](/images/extremecours_fleche.png)
![Extreme 0.501](/images/extremecours_fleche.png)
![Extreme 0.501](/images/extremecours_fleche.png)
![Extreme 0.501](/images/extremecours_fleche.png)
![Extreme 0.501](/images/extremecours_fleche.png)
![Extreme 0.501](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Founder | 50 | 14-03-11 | |
Michael Rowe
CEO | Chief Executive Officer | 62 | 18-07-08 |
John Gandolfo
DFI | Director of Finance/CFO | 63 | 17-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | Nov. 13 | |
Ellen Strahlman
BRD | Director/Board Member | 66 | - |
Michael Rowe
CEO | Chief Executive Officer | 62 | 18-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +6.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-12 | 1.07 | +7.32% | 1,267,789 |
24-07-11 | 0.997 | +6.15% | 1,616,099 |
24-07-10 | 0.9392 | +2.81% | 709,977 |
24-07-09 | 0.9135 | +4.04% | 496,935 |
24-07-08 | 0.878 | +0.69% | 1,389,423 |
Delayed Quote Nasdaq, July 12, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.56% | 73.85M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- EYEN Stock